Black Diamond Therapeutics BDTX 深 滬
等待開盤 12-18 09:30:00 美东时间
2.59
-0.030
-1.15%
華盛通- 最 高2.72
- 今 開2.64
- 成交量 86.10万股
- 最 低 2.59
- 昨 收 2.62
- 總市值 1.48亿
- 52周最高 4.94
- 市盈率 靜 --
- 換手率 1.51%
- 52周最低 1.195
- 委 比 56.08%
- 總股本 5697.49万
- 歷史最高 46.25
- 量 比 0.85
- 振 幅 4.96%
- 歷史最低 1.18
- 每 手 1
- 風險率 0.79%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Guggenheim Downgrades Black Diamond Therapeutic to Neutral
Guggenheim analyst Brad Canino downgrades Black Diamond Therapeutic (NASDAQ:BDTX) from Buy to Neutral.
12-04 21:48
Black Diamond Therapeutics To Present Results From Phase 2 Clinical Study Of Silevertinib On Dec. 3
Black Diamond Therapeutics, Inc. (NASDAQ:BDTX), a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer, will host a webcast to present results
12-03 05:02
美股大行评级 | Stifel上调英伟达目标价升至250美元；大摩上调哔哩哔哩目标价升至27美元；NICE遭多家机构下调目标价
今日重点评级关注：Oppenheimer：维持Olema Pharmaceuticals"跑赢大市"评级，目标价从22美元升至45美元；Bernstein：维持Atlassian"跑赢大市"评级，目标价从290美元升至304美元
11-19 11:01
Black Diamond Therapeutic Q3 EPS $(0.15) Beats $(0.23) Estimate
Black Diamond Therapeutic (NASDAQ:BDTX) reported quarterly losses of $(0.15) per share which beat the analyst consensus estimate of $(0.23) by 35.9 percent. This is a 46.43 percent increase over losses of $(0.28) per
11-06 20:35
Black Diamond Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update
Black Diamond Therapeutics reported financial results for Q3 2025, highlighting $135.5 million in cash, sufficient for operations into Q4 2027. The company plans to disclose ORR and preliminary duration data for silevertinib in 1L EGFRm NSCLC later this quarter. R&D expenses decreased to $7.4 million, and net loss was $8.5 million. Black Diamond is seeking partnerships and FDA feedback for silevertinib's development.
11-06 12:30
Clarus Announces $0.025 Per Share Quarterly Dividend
Clarus Corporation announced a quarterly cash dividend of $0.025 per share, payable on November 26, 2025, to stockholders of record as of November 17, 2025. Headquartered in Salt Lake City, Utah, Clarus is a global leader in outdoor equipment and lifestyle products, with brands including Black Diamond®, Rhino-Rack®, MAXTRAX®, TRED Outdoors®, and RockyMounts®.
11-05 21:15
美股大行评级 | Needham上调台积电目标价升至360美元！美国银行、摩根士丹利分别获多家机构上调目标价
今日重点评级关注：Rosenblatt：维持HIVE Digital Technologies"买入"评级，目标价从5美元升至10美元；摩根大通：维持Array Technologies"超配"评级，目标价从13美元升至15美元
10-17 09:58
Stifel Reinstates Buy on Black Diamond Therapeutic, Announces $8 Price Target
Stifel analyst Laura Prendergast reinstates Black Diamond Therapeutic (NASDAQ:BDTX) with a Buy and announces $8 price target.
10-16 21:50
封堵心脏漏洞的国产之光！太平基金重仓押注无忧跳动，卵圆孔未闭治疗迎来黄金时代 | 每日速递
来源：IT桔子 IT桔子出品 投资 13 October 星期一 每日风险投资速递 TIPS： 1、下载 IT桔子 APP，实时跟...
10-14 15:02
